350 related articles for article (PubMed ID: 15356145)
1. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation.
Arnaud M; Crouin C; Deon C; Loyaux D; Bertoglio J
J Immunol; 2004 Sep; 173(6):3962-71. PubMed ID: 15356145
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
[TBL] [Abstract][Full Text] [Related]
3. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
4. Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a.
Brockdorff JL; Gu H; Mustelin T; Kaltoft K; Geisler C; Röpke C; Ødum N
Exp Clin Immunogenet; 2001; 18(2):86-95. PubMed ID: 11340297
[TBL] [Abstract][Full Text] [Related]
5. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
6. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
7. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
8. Ligation of CD28 stimulates the formation of a multimeric signaling complex involving grb-2-associated binder 2 (gab2), SRC homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the gab2 pleckstrin homology domain.
Parry RV; Whittaker GC; Sims M; Edmead CE; Welham MJ; Ward SG
J Immunol; 2006 Jan; 176(1):594-602. PubMed ID: 16365455
[TBL] [Abstract][Full Text] [Related]
9. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
11. Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration.
Yu WM; Hawley TS; Hawley RG; Qu CK
Blood; 2002 Apr; 99(7):2351-9. PubMed ID: 11895767
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide 3-kinase-dependent regulation of interleukin-3-induced proliferation: involvement of mitogen-activated protein kinases, SHP2 and Gab2.
Craddock BL; Hobbs J; Edmead CE; Welham MJ
J Biol Chem; 2001 Jun; 276(26):24274-83. PubMed ID: 11335710
[TBL] [Abstract][Full Text] [Related]
13. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.
Yamasaki S; Nishida K; Hibi M; Sakuma M; Shiina R; Takeuchi A; Ohnishi H; Hirano T; Saito T
J Biol Chem; 2001 Nov; 276(48):45175-83. PubMed ID: 11572860
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
15. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
16. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
17. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
18. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
19. SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.
Lundin Brockdorff J; Woetmann A; Mustelin T; Kaltoft K; Zhang Q; Wasik MA; Röpke C; Ødum N
Cytokine; 2002 Nov; 20(4):141-7. PubMed ID: 12543077
[TBL] [Abstract][Full Text] [Related]
20. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
Zhu QS; Robinson LJ; Roginskaya V; Corey SJ
Blood; 2004 May; 103(9):3305-12. PubMed ID: 14656892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
